Pharmacyclics, Inc. (PCYC) Tops Q1 EPS by 39c
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q1 EPS of $1.14, $0.39 better than the analyst estimate of $0.75. Revenue for the quarter came in at $102.7 million versus the consensus estimate of $87.64 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%
- Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
